Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05340296 · ClinicalTrials.gov registry record · NA
Network Health Intervention for Adolescents Leaving Acute Psychiatric Care
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05340296: Clinical Trial NA study, sponsored by University of Rochester.
NCT05340296 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05340296, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to refine and then assess the feasibility, acceptability, and target engagement of Acute Youth Connect - a network health intervention for adolescents leaving acute psychiatric care with suicide-related concerns.
Primary Outcome
Youth subjects who complete all three interactive sessions will be marked as "treatment completers."
Interventions
- BEHAVIORAL Acute Youth Connect
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2023-10-06 |
| Phase | NA |
Why NCT05340296 stopped before completion
NCT05340296 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Acute Youth Connect is the first listed.
NCT05340296 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05340296 about?
NCT05340296 is a clinical study titled "Network Health Intervention for Adolescents Leaving Acute Psychiatric Care". The purpose of this pilot study is to refine and then assess the feasibility, acceptability, and target engagement of Acute Youth Connect - a network health intervention for adolescents leaving acute psychiatric care with suicide-related concerns.
What is the current status of trial NCT05340296?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2022-07-01. Estimated completion is 2023-10-06.
What interventions are being tested in trial NCT05340296?
The interventions under investigation include: Acute Youth Connect (BEHAVIORAL).
Who is sponsoring clinical trial NCT05340296?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05340296's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI